Moreover, large‐scale genomic surveys identified mutations in the telomerase reverse transcriptase (TERT) gene, which encodes the catalytic reverse transcriptase subunit of telomerase, as one of the most prevalent genetic changes in a wide variety of tumours [27, 28]. Here, TERT is linked to neoplasm.